PREBOOK THIS REPORT - SAVE 10%

Specialty Enzymes Market - Global Outlook & Forecast 2022-2027

TO BE PUBLISHED : Dec 2022 | Pages : 261

THE SPECIALTY ENZYMES MARKET SIZE WAS VALUED AT USD 2.96 BILLION IN 2021 AND IS EXPECTED TO REACH USD 4.56 BILLION BY 2027, GROWING AT A CAGR OF 6.26%.

The Global Specialty Enzymes Market Size, Share, & Trends Analysis Report By

  • Type: Carbohydrase, Proteases, Lipases, and Polymerases & nucleases
  • End Use: Pharmaceutical, Biotechnology, Diagnostics, and Other Specialty
  • Source: Microorganisms, Plants, and Animal
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027

Prebook Tag
Licence Types What are these?
10 % OFF

Save 10% on this report.
Discount already applied

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

261 Pages

icon-table

116 Tables

icon-chart

91 Charts

icon-region

5 Regions

icon-country

16 Countries

icon-company

20 Companies

icon-market

4 Market Segment

SPECIALTY ENZYMES MARKET REPORT SCOPE

Report Attribute Details
Market Size (2027) USD 4.56 Billion
Market Size (2021) USD 2.96 Billion
CAGR (2022-2027) 6.26%
Base Year 2021
Forecast Year 2022-2027
Market Segments Type, End Use, Source, and Geography
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
KEY VENDORS BASF SE, DSM, DuPont, F. Hoffmann-La Roche Ltd, and Novozymes

The global specialty enzymes market size crossed USD 2.96 billion in 2021 and is expected to reach USD 4.56 billion by 2027, growing at a CAGR of 6.26% from 2021-2027. Factors such as the rapidly increasing global population, increasing research & development, spreading new infectious diseases, increasing biofuel usage, and growing agriculture industry led to increased demand for specialty enzymes in the global market. The major drivers of the specialty enzymes market include the increasing health consciousness and intense penetration of the pharmaceutical, diagnostics, and biotechnology industries.

Specialty enzymes are used in various industries for various purposes. In the pharmaceutical industry, these are used for manufacturing drugs for DNA/RNA treatment, cancer, heart-related disease, and other treatments. The demand is increasing due to increasing awareness and changing government policies. With the growing specialty enzymes markets, companies must increase the supply of raw materials to produce enzymes in bulk quantities. In the pharmaceutical industry, companies have started using biobased drugs to improve product quality. Companies are adopting sustainable standards in their manufacturing processes. The specialty enzymes market has helped to reduce the by-products in the production process. Companies are getting good financial returns by using specialty enzymes in the production processes. Thus, the global demand for specialty enzymes is increasing.

The US contributed more than half of the overall demand in North America. Globally, the demand for specialty enzymes is very high in the US, and North America dominates the global specialty enzymes market. The US has the world’s top 10 pharmaceutical companies’ head offices. Thus, the demand for specialty enzymes in North America's pharmaceutical industry is increasing with the growing pharmaceutical industry.

MARKET TRENDS & DRIVERS

Increased Use in Diagnostics Sector
The diagnostics industry includes two categories such as pathology and radiology. Pathology is used for testing all types of illness, whereas radiology is used for testing images related to diagnoses such as x-rays, CT scans, and others. For the research & development of vaccines for various infectious diseases, enzymes are used. Enzymes are used in testing infectious diseases such as coronaviruses and influenza and are also used in nucleic acid detection. The enzymes are used in the diagnostics and analysis of biological abnormalities.

The diagnostics segment plays a crucial role in the healthcare sector. After the Covid-19 pandemic, the demand for proper diagnostic equipment and processes in the diagnostics sector is growing rapidly. In the testing of coronaviruses and other infectious diseases, enzymes are used. For immediate recovery from coronavirus diseases, antibiotics are used, which are produced from enzymes. Thus, the specialty enzymes market in the diagnostic sector is increasing globally.

Increasing Demand from Pharmaceutical Industry
The global revenue of the pharmaceutical industry is increasing due to the global demand for pharmaceutical products. The factors driving the demand for pharmaceutical products include changing clinical practices, aging-related issues, and rising chronic diseases. After the Covid-19 pandemic, the demand for pharmaceutical products used to improve quality of life and preventive approach. The global market of pharmaceutical drugs is increasing due to the lowering the regulatory barrier for new drugs in the US.

The health consciousness of people has increased after the Covid-19 pandemic. People prefer bio-based pharmaceutical products. Thus, the demand for bio-based substances used in manufacturing antibiotics is rising. Specialty enzymes are used in the pharmaceutical industry to increase the reaction rate and produce the desired molecules, contributing to the specialty enzymes market growth.

INDUSTRY RESTRAINTS

Technical Barriers Affecting Specialty Enzymes Market
Biocatalysis is a process that accelerates the chemical process by using biomolecules. It includes mild reaction and high selectivity conditions. Therefore, specialty enzymes play an essential role in the chemical industry and are gaining relevance in industrial applications. But, there is difficulty in finding the accurate protein structure of specialty enzymes. The process is time-consuming and requires more catalysts to fulfilling the need of the chemical reaction process. For the manufacturing process of these enzymes, specific conditions such as new concentration, new substrate, and other conditions are required which are not found readily in nature. These unresolved challenges make specialty enzymes unpredictive. Thus, more research & development is necessary for making enzymes in bulk amounts, creating a barrier to the specialty enzymes market growth.

SEGMENTATION INSIGHTS

INSIGHTS BY END-USE
In the pharmaceutical industry, specialty enzymes are very useful and good for treating various diseases. As there is increasing demand for pharmaceutical products, the enzyme has become essential to meet the demand for sustainable and safe industry processes. The specialty enzymes are primarily used in the pharmaceutical and biotechnology industry for research & development and diagnostics. The global specialty enzymes market in the pharmaceutical industry was valued at USD 976.56 million in 2021. The demand for specialty enzymes in North America and APAC is very high due to the increasing pharmaceutical and biotechnology industry. 

In the biotechnology industry, specialty enzymes are used to increase biochemical reaction rates. Lipases are used in dietary drugs and it is used to increase the metabolism rate. Polymerases & nucleases are used in DNA amplification. In DNA amplification, the increase in the number of the gene causes an increase in proteins and RNA. Thus, it may increase the cancer cells or lower the anticancer cells. Hence, the polymerases & nucleases-based enzymes demand is growing in the global specialty enzymes market.

INSIGHTS BY TYPE
Carbohydrases have dominated the global specialty enzymes market and is expected to reach USD 1.9 billion by 2027. Carbohydrases are mainly used in the pharmaceutical industry as specialty enzymes. Most of these enzymes used in the pharmaceutical industry are produced from microorganisms, animals, and plants. Carbohydrases are further classified into glucosidase, pectinases, alpha, beta amylases, cellulases, mannanases, galacto, and pullulanase. These are the cost-effective processes in industrial applications; thus, a cheap technique is required to obstruct.

The global proteases-based specialty enzymes market surpassed  USD813 million in 2021. The proteases are used in the biotechnology, pharmaceutical, and diagnostics industries—the high use of proteases in the pharmaceutical industry for prognostic and diagnostic biomarkers. Based on the catalysis mechanism, the proteases are classified into additional classes, such as glutamic, aspartic, metalloproteases, threonine, cysteine, and serine proteases which activate the water molecule and attack the proteins.

INSIGHTS BY SOURCE
Globally, microorganisms-based enzymes contributed 77.47%, followed by animal and plant-based enzymes in 2021 in the global specialty enzymes market. The demand for specialty enzymes is very high in North America, followed by Europe and APAC. Microorganisms and plant-based enzymes are easily found in the environment. Animal-based enzymes have fewer resources, and it isn't easy to produce in bulk quantities. Thus, companies are focusing on producing enzymes from microorganisms and plants.

The global plants-based specialty enzymes market was valued at USD 297.07 million in 2021. These are used in the agriculture industry to reduce insects from crops. The few plant-based enzymes are phosphatase, esterase, glucanase, chitinase, and others. These enzymes play a crucial role in the production of nutrition. Further, plant-based enzymes are being used to manufacture drugs in the pharmaceutical industry to improve the digestive system.

GEOGRAPHICAL ANALYSIS

The global specialty enzymes market is diverse, with many established and potential growth markets. North America is the leading market because of rapidly developing infrastructure and readily increasing population, increasing demand for various pharmaceutical, biotechnology, and diagnostics industries. The specialty enzymes market in North America was valued at USD 1.2 billion in 2021.

Europe is the second-largest market for specialty enzymes. The growth is supported by the increasing demand for healthy pharmaceutical products, which is attributed to the rising health consciousness. Germany, France, Italy, Spain, the UK, Russia, and others led the region. In European countries, various companies are producing specialty enzymes that contribute to the global specialty enzymes market, such as BASF SE (Germany), Johnson Matthey (UK), Biocatalysts (UK), BBI Solutions (UK), and others. Furthermore, the demand is expected to grow significantly as the APAC region population has grown tremendously in recent years. China, Japan, India, and South Korea led the region. The population of APAC countries is increasing rapidly; thus, demand for pharmaceutical and diagnostics specialty enzymes is increasing. China, India, and Japan are the major pharmaceutical industry players in the APAC region.

COMPETITIVE LANDSCAPE

The major companies in the specialty enzymes market are following the merger and acquisition strategy. This gives companies a competitive advantage that boosts their market share of the company. The key companies have undertaken various strategies to grow in the market. The growth in sustainable processes and initiatives has challenged all companies globally. Investments in R&D, technological advancement, and environmental and economic challenges drive the demand for innovative and sustainable specialty enzyme products.

Some major players in the global specialty enzymes market include Roche (Switzerland), BASF SE (Germany), DuPont (US), Novozymes (Denmark), and DSM (Netherlands). These players have adopted strategies like acquisitions, expansion, joint ventures, new product development, and others to increase their revenues in the industry. Other prominent companies such as Chr. Hansen Holding A/S (Denmark), Codexis (US), BBI Solutions (UK), and others have invested significant capital in R&D to develop specialty enzymes-based products that will appeal to customers. Therefore, these other prominent companies are giving tough competition to major companies.

Frequently Asked Questions

What was the global specialty enzymes market size in 2021?

The global specialty enzymes market size surpassed USD 2.96 billion in 2021 and is expected to reach USD 4.56 billion by 2027.

What is the growth rate of the global specialty enzymes market?

The global specialty enzymes market share is growing at a CAGR of 6.26% from 2022-2027.

What are the key trends in the Specialty Enzymes Market in the world?

The increasing demand from the pharmaceutical industry, adopting sustainability standards to improve profitability and productivity, and growing demand from emerging economies are key trends in the global specialty enzymes market.

Which are the key companies in the global specialty enzymes market?

The key global specialty enzymes market companies are BASF SE, DSM, DuPont, F. Hoffmann-La Roche Ltd, and Novozymes.

Which end-use segment is estimated to lead the Global Specialty Enzymes Market?

The pharmaceutical industry is estimated to dominate the global specialty enzymes market by end-use and will reach USD 1.4 billion by 2027. Due to the growth in the global population, the demand for pharmaceutical products is increasing. Due to people becoming more health conscious, pharmaceutical companies focus on increasing the bio-based drug content in drug formulations.

Download Free Sample

The specialty enzymes market is expected to grow at a CAGR of approximately 6.26% from 2022 to 2027.

The following factors are likely to contribute to the growth of the specialty enzymes market during the forecast period:

  • Increase in Demand from Bio-Sourced Products
  • Increased Use in Diagnostics Sector
  • Increased R&D and Product Innovations in Developed Countries

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the specialty enzymes market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.

Key Vendors

  • BASF SE
    • Business Overview
    • Financial Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • DSM
  • DuPont
  • F. Hoffmann-La Roche Ltd
  • Novozymes

Other Prominent Vendors

  • Amano Enzyme Inc.
    • Company Overview
    • Business Overview
    • Product Offerings
  • Amayra Biotech AG
  • Antozyme Biotech Pvt Ltd
  • Aumgene Biosciences
  • Aumenzymes
  • BBI Solutions
  • Biocatalysts
  • Codexis
  • Hansen Holding A/S
  • Dyadic International Inc.
  • Iosynth
  • Merck KGaA
  • Nature Bioscience Pvt. Ltd.
  • Specialty Enzymes & Probiotics
  • Zymtronix Inc.

Segmentation by Type

  • Carbohydrase
  • Proteases
  • Lipases
  • Polymerases & nucleases

Segmentation by End Use

  • Pharmaceutical
  • Biotechnology
  • Diagnostics
  • Other Specialty

Segmentation by Source

  • Microorganisms
  • Plants
  • Animal

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Russia
    • Rest of Europe
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

For more details, please reach us at enquiry@arizton.com

For more details, please reach us at enquiry@arizton.com

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Prebook Tag
Licence Types What are these?
10 % OFF

Save 10% on this report.
Discount already applied

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date